PYPD · PolyPid Ltd.
$4.74
-0.04 (-0.84%)
At close · Aug 14
Market Cap
$90.89M
Shares
19.17M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.74
Open$4.77
Day$4.60–4.81
52W close$3.15–5.58
Avg vol 30d288K
Short int413K · 2.2% float · 1.1d
Short vol44%
Last earningsApr 19, 2026
DataSep 2023–Aug 2026
Raw chart and full-history price indicators begin at the captured split on Sep 21, 2023; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+8%
above
Price vs 50-day avg
+0%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
65%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−12%
trailing
6-month return
+12%
trailing
YTD return
+9%
this year
Relative strength
−2%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+65% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.15% of float · ▲ +45.8% MoM · 1.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
33 holders — near 3-yr high, broad support
Squeeze score
56
elevated · 0–100
Fundamentals
EPS growth
−57%
Y/Y
Free cash flow
$-28.1M
Balance sheet
$4.8M
net cash
Quant / Vol
risk profile
Volatility
55%
annualized · 1-yr
Max drawdown
−33%
past year
ATR
6.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+8%
Bullish
Price vs 50-day avg
+0%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
65%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+65% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.15% of float · ▲ +45.8% MoM · 1.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
33 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3
Now $5 · 65%
Range high $6
vs 200-day avg +8%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PYPD
this stock
PolyPid Ltd.
|
$90.89M | +9.2% | — | — | 2.2% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
33
- % held
- 17.2%
- Net QoQ
- +168.7K sh
- Top holder
- Rodney Hodges
Held
Float
Short & Settlement
Financials
Filings
Performance
Raw-price comparisons begin at the captured split on Sep 21, 2023; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PYPD | -2.1% | -11.7% | +11.8% | +10.5% | +9.2% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -2.5% | -16.2% | -2.0% | +6.6% | -4.6% |
Key facts
CIK
1611842
CUSIP
M8001Q126
13F (30d)
34 filings
33 filers
Visit website
Investor relations